P. Castrogiovanni, A. Di Muro, A. Goracci, L. Guidelli - Vol. 7, Dicembre 2001, num.4
Testo Immagini Bibliografia Summary Riassunto Indice
Confini tra disturbo ossessivo-compulsivo
e depressione: considerazioni psicopatologiche
Limits between obsessive-compulsive disorder
and depression: psychopathological considerations
1 Black DW, Goldstein RB, Noyes R Jr, Blum N. Psychiatric disorders in relatives of probands with obsessive-compulsive disorder and co-morbid major depression or generalized anxiety. Psychiatry 1995;5:37-41.
2 Rachman SJ, Hodgson RJ. Obsessions and compulsions. Englewood Cliffs: Prentice-Hall 1980.
3 Rasmussen SA, Tsuang MT. Clinical characteristics and family history in DMS-III obsessive-compulsive disorder. Am J Psychiatry 1986;143:317-22.
4 Gittleson NL. The phenomenology of obsessions in depressive psychosis. Br J Psychiatry 1966;112:261-4.
5 Kendell RE, Di Scipio WJ. Obsessionals symptoms and obsessional personality traits in patients with depressive illness. Psychological Med 1970;1:65-72.
6 Videback T. The psychopathology of anancastic endogenous depression. Acta Psychiatrica Scand 1975;52:336-73.
7 Vaughan M. The relationship between obsessional personality, obsessions in depression, and symptoms of depression. Br J Psychiatry 1976;129:36-9.
8 Reynolds M, Salkovskis PM. Comparison of positive and negative intrusive thoughts and experimental investigation of the differential effects of mood. Behav Res Ther 1992;30:273-81.
9 Lion EG. Anancastic depression:obsessive-compulsive symptoms occurring during depression. J Nerv Mental Dis 1942;95:730-8.
10 Di Muro A, Goracci A, Luccarelli L, Pacciani MG, Castrogiovanni P. Specificità e aspecificità delle dimensioni ossessivo-compulsive. Giorn It Psicopatologia 1999;5:52-3.
11 Di Muro A, Goracci A, Luccarelli L, Pacciani MG, Castrogiovanni P. Obsessive-Compulsive Dimensions. American Psychiatric Association Annual Meeting, Washington: Poster Session 1999.
12 Tynes LL, Winstead DK. Subtyping obsessive compulsive patients by depressive symptoms: a retrospective pilot study. Psych Quarterly 1999;70:53-61.
13 Perugi G, Akiskal H, Pfanner C, Presta S, Gemignani A, Milanfranchi A, et al. The clinical impact of bipolar and unipolar affective comorbidity on obsessive-compulsive disorder. J Affect Dis 1997;46:15-23.
14 Coryell W, Endicott J, Winokur G. Anxiety syndromes as epiphenomena of primary major depression. Outcome and familial psychopathology. Am J Psychiatry 1992;149:100-7.
15 Rasmussen SA, Eisen JL. The epidemiology and differential diagnosis of obsessive-compulsive disorder. J Clin Psychiatry 1992;53:4-10.
16 Lempérière T, Rondepierre C. Clinique et aspects actuels des troubles obsessionnels. Encéphale 1990;16:293-8.
17 Kruger S, Cooke RG, Hasey GM, Jorna T, Persal E. Comorbidity of obsessive-compulsive disorder. J Affect Dis 1995;34:117-20.
18 Foa EB, Grayson GB, Steketee GS, Doppelt HG, Turner RM, Latimer PR. Success and failure in the behavioral treatment of Obsessive-Compulsive Disorder. J Cons Clin Psychology 1983;51:287-97.
19 Steketee G, Doppelt H. Measurement of obsessive-compulsive symptomatology: utility of the Hopkin's symptoms checklist. Psychiatry Res 1986;19:135-45.
20 Zitterl W, Lenz G, Mairhofer A, Zapotoczky HC. Obsessive-Compulsive disorder: course and interaction with depression. A review of the literature. Psychopathology 1990;23:73-80.
21 Ravizza L, Maina G, Bogetto F. Episodic and chronic obsessive-compulsive disorder. Depression and Anxiety 1997;6:154-8.
22 Tellembach H. Melanconia. Roma: Il Pensiero Scientifico Editore 1975.
23 Black DW, Yates WR, Noyes R, Pfhol B, Kelley M. DSM III personality disorder in obsessive-compulsive study volunteers: a controlled study. J Personality Dis 1989;3:58-62.
24 Kusunoki K, Sato T, Taga C, Yoshida T, Komori K, Narita T, et al. Low novelty-seeking differentiates obssessive-compulsive disorder from major depression. Acta Psychiatrica Scandinavica 2000;101:403-5.
25 Insel TR, Mueller EA, Alterman I, Linnoila M, Murphy DL. Obsessive-Compulsive disorder and serotonin: is there a connection? Biol Psychiatry 1985;20:1174-88.
26 Weizman A, Carmi M, Hermesh H, Shahar A, Apter A, Tyano S, et al. Higt-affinity imipramine binding and serotonin uptake in platelets of eight adolescent and ten adult obsessive compulsive patients. Am J Psychiatry 1986;143:335-9.
27 Marazziti D, Perugi G, Delito J, Lensi A, Maremmani I, Placidi GF, et al. High-affinity 3H-imipramine binding sites: a possible state-dependent marker for mayor depression. Psychiatry Research 1988;23:229-37.
28 Black DW, Kelly M, Myers C, Noyes R. Tritiated imipramine binding in obsessive-compulsive volunteers and psychiatrically normal controls. Biol Psychiatry 1990;27:319-27.
29 Kim SW, Dysken MW, Pandey GN, Davis JM. Platelet 3H-imipramine binding sites in obsessive-compulsive behavior. Biol Psychiatry 1990;30:467-74.
30 Bastani B, Arora RC, Melzer HY. Serotonin uptake and imipramine binding in the blood platelets of OCD patients. Biol Psychiatry 1991;30:131-9.
31 Vitiello B, Shimon H, Behar D, Staff D, Bridger WH, Friedman E. Platelet imipramine binding and serotonin uptake in obsessive-compulsive patients. Acta Psychiatrica Scandinavica 1991;84:29-32.
32 Vallejo J, Olivares J, Marcos T, Martìnez-Osaba MJ, Ribera F, Bulbena A. Dexamethasone suppression test and primary obsessional compulsive disorder. Comprehensive Psychiatry 1988;29:498-502.
33 Bellodi L, Sciuto G, Diaferia G, Ronchi P, Smeraldi E. Psychiatric disorders in the families of patients with Obsessive Compulsive Disorder. Psychiatry Res 1992;42:111-20.
34 Meltzer HY, Lowy MT. The serotonin hypothesis of depression. In: Meltzer HY, ed. Psychopharmacology: the third generation of progress. New York: Raven Press 1987:513-26.
35 Baron M, Barkai A, Gruen R, Peselow E, Fieve RR. High-affinity 3H-imipramine binding sites in affective disorders: traits versus state characteristics. Am J Psychiatry 1986;143:711-7.
36 Briley MS, Canger SZ, Kaisman R, Sechter D, Zarifian E. Tritiated imipramine binding sites are decreased in platelets from untreated depressed patients. Science 1980;209:303-5.
37 Rosel P, Arranz B, Vallejo J, Alvarez P, Menchon JM, Palencia T, et al. Altered [3H] imipramine and [5HT2] but not [3H] paroxetine binding sites in platelets from depressed patients. J Affective Dis 1999;52:225-33.
38 Ravindran AV, Griffiths J, Merali Z, Anisman H. Circulating lynphocyte subsets in obsessive compulsive disorder, major depression and normal control. J Affective Dis 1999;52:1-10.
39 Lopez-Ibor JJ, Saiz Ruiz J, Lopez-Ibor MI, Vinas Pifarre R. Obsessive-compulsive disorder and depression. Actas Luso-Espanolas de Neurologia, Psiquiatria Y Ciencias Afines 1995;23:97-113.
40 Ohara K, Suzuki Y, Ochiai M, Tsukumoto T, Toni K. A variable-number-tandem-repeat of the serotonin transporter gene and anxiety disorders. Progress in Neuropsychopharmacol Biol Psichiatry 1999;23:55-65.
41 Mc Dougle CJ, Epperson CN, Price LH, Gelernter J. Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive-compulsive disorder. Mol Psychiatry 1998;3:270-3.
42 Billet EA, Richter MA, King N, Heils A, Lesch KP, Kennedy JL. Obsessive-Compulsive disorder, response to serotonin reuptake inhibitors and the serotonin transporter gene. Mol Psychiatry 1997;2:403-6.
43 Purcell R, Maruff P, Kyrios M, Pantelis C. Neuropsychological deficits in obsessive-compulsive disorder: a comparison with unipolar depression, panic disorder, and normal controls. Arch Gen Psychiatry 1998;55:415-23.
44 Baxter L, Schwartz J, Mazziotta JC, Phelps ME, Pahal JJ, Guze BH, et al. Cerebral glucose metabolic rates in nondepresed obsessive-compulsives. Am J Psychiatry 1988;145:1560-3.
45 Baxter L, Phelps M, Mazziotta JC, Guze BH, Schwartz JM, Selin CE. Local cerebral metabolic rates in obsessive-compulsive disorder: a comparison with rates in unipolar depression and normal controls. Arch Gen Psychiatry 1987;44:211-8.
46 Mc Guire PK, Bench CJ, Frith CD, Marks IM, Frackowiak RS, Dolan RJ. Functional anatomy of obsessive-compulsive phenomena. Br J Psychiatry 1994;164:459-68.
47 Rauch SL, Jenike MA, Alpert NM, Baer L, Breiter HC, Savage CR, et al. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry 1994;51:62-70.
48 Cavedini P, Ferri S, Scarone S, Bellodi L. Frontal lobe dysfunction in obsessive-compulsive disorder and major depression: a clinical-neuropsychological study. Psychiatry Res 1998;78:21-8.
49 Thoren P, Asberg M, Cronholm B, Jornested L, Traskman L. Clomipramine treatment of Obsessive Compulsive-Disorder. I. A controlled clinical trial. Arch Gen Psychiatry 1980;37:1281-5.
50 Ananth J, Pecknold JC, Van den Steen N, Englesmann F. Double-bind comparative study of clomipramine and amitriptyline in obsessive neurosis. Progress in Neuropsychopharmacol Biol Psychiatry 1981;5:257-62.
51 Volavka J, Neziroglu F, Yaryura-Tobias JA. Clomipramine and imipramine in obsessive-compulsive disorder. Psychiatry Res 1985;14:85-93.
52 Zohar J, Insel TR. Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment and pathophysiology. Biol Psychiatry 1987;22:667-87.
53 Leonard HL, Swedo SE, Rapoport JL, Koby EV, Lenane MC, Cheslow DL, et al. Treatment of obsessive-compulsive disorder with desipramine and desmethylimipramine in children and adolescents: a double-blind crossover comparison. Arch Gen Psychiatry 1989;46:1088-92.
54 Goodman WK, Price LH, Delgado PL, Riddle MA, Pauls DL, Leckeman JF. Specificity of SRI in the treatment of obsessive compulsive disorder. Comparison of fluvoxamine and desipramine. Arch Gen Psychiatry 1990;47:577-85.
55 Insel TR, Murphy DL, Cohen M, Alterman I, Kitts C, Linnoila M. Obsessive-Compulsive disorder: a double-blind trial of clomipramine and clorgyline. Arch Gen Psychiatry 1983;40:605-12.
56 Vallejo J, Olivares J, Marcos T, Bulbena A, Menchon JM. Clomipramine versus phenelzine in obsessive compulsive disorder. A controlled clinical trial. British J Psychiatry 1992;161:665-70.
57 Goodman WK, McDougle CJ, Price LH. Pharmacotherapy of obsessive-compulsive disorder. J Clin Psychiatry 1992;53;29-37.
58 Katz RJ, De Veaugh-Geiss J. The antiobsessional effect of clomipramine do not require concomitant affective disorder. Psychiatry Res 1990;31:121-9.
59 Den Boer JA. Psychopharmacology of comorbid obsessive-compulsive disorder and depression. J Clin Psychiatry 1997;58:17-9.
60 Pato MT, Hill JL, Murphy DL. A clomipramine dosage reduction study in the course of long-term treatment of obsessive-compulsive patients. Psychopharmacol Bull 1990;26:211-4.
61 Leonard HL, Swedo SE, Lenane MC, Rettew DC, Cheslow DL, Hamburger SD, et al. A double-blind desipramine substitution during long term clomipramine treatment in children and adolescent with obsessive-compulsive disorder. Arch Gen Psychiatry 1991;48:922-7.
62 Janet P, Raymond F. Les obsessions et la psychastenie. Paris: Alcan 1919.